EUVIMEDEUVIMED entdecken
Crossref

Validation of an HPLC‐UV for Apixaban Stability‐Indicating Study

Emna Bellaaj iD, Ameni Elleuch, Kaouthar Louati iD

Biomedical Chromatography · 2026-07 · 40 (7)

DOI: 10.1002/bmc.70496 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 26.05.2026. Verfasst von Emna Bellaaj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Laboratory of Analytical Chemistry, University of Monastir, Monastir, Tunisia. Hauptthemen laut MEDLINE: Pyrazoles, Pyridones. Die Arbeit nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Apixaban is a new generation oral anticoagulant drug, which selectively inhibits the coagulation factor Xa. Currently, there is no official monograph available in the pharmacopoeias for apixaban finished pharmaceutical form, allowing stability study. Therefore, the objective of this study was to validate a new simple analytical method by HPLC‐UV detection for apixaban stability study. Our method was issued from the USP monograph under elaboration, which consisted of (ODS‐3V)‐C18 column (250 mm × 4.6 mm, 5 μm), and a mobile phase at polarity gradient composed of ammonium acetate solution at 0.77 g/L and acetonitrile (80:20, v/v) as mobile phase A and acetonitrile as a mobile phase B. The flow rate was set at 1 mL/min, the injection volume at 10 μL, the wavelength at 280 nm, and the temperature at 45°C. The obtained results showed that apixaban was relatively stable under degradation conditions involving temperature, oxidation and UV. However, it was less stable under acidic and basic hydrolysis. Our method was then validated according to the ICH guidelines that were proved to be specific, linear, accurate and precise. Hence, it can be considered as a stability indicating method and suitable also for routine quality control analysis of apixaban in liquid pharmaceutical forms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyrazolesPyridonesChromatography, High Pressure LiquidDrug StabilityReproducibility of ResultsLinear ModelsLimit of DetectionSpectrophotometry, Ultraviolet

Stichwörter der Autor:innen

HPLC‐UVapixabanstability indicating

Substanzen

PyrazolesapixabanPyridones

Autor:innen und Institutionen

  • Faculty of Pharmacy, Laboratory of Analytical Chemistry, University of Monastir, Monastir, Tunisia.
  • Department of Drug Control and Development-Road of SIDI-SALEH, Philadephia Derma Pharmaceutical Laboratories, Sfax, Tunisia.
  • Habib Bourguiba University Hospital, Sfax, Tunisia.

ORCID-Profile: Emna Bellaaj, Kaouthar Louati

Zitieren

APA

Bellaaj, E., Elleuch, A., & Louati, K. (2026). Validation of an HPLC‐UV for Apixaban Stability‐Indicating Study. Biomedical Chromatography, 40(7). https://doi.org/10.1002/bmc.70496

Vancouver

Bellaaj E, Elleuch A, Louati K. Validation of an HPLC‐UV for Apixaban Stability‐Indicating Study. Biomedical Chromatography. 2026;40(7). doi:10.1002/bmc.70496

BibTeX
@article{Bellaaj2026,
  author = {Bellaaj, Emna and Elleuch, Ameni and Louati, Kaouthar},
  title = {Validation of an HPLC‐UV for Apixaban Stability‐Indicating Study},
  journal = {Biomedical Chromatography},
  year = {2026},
  volume = {40},
  number = {7},
  doi = {10.1002/bmc.70496}
}
Kostenlos starten →